We offer partnership opportunities with our mucOne antibodies, which are ready for preclinical evaluation in therapeutic applications.
Our validated antibodies specifically target Tn/STn-mucin-1, making them ideal candidates for cancer immunotherapy development.
We provide flexible option agreements tailored to our partners' needs and can supply antibody samples to support preclinical data generation.
Company Details
- Address
- Diplomvej 381, 381,denmark
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- HQ
- Kongens Lyngby, Capital Region of Denmark
Mucone Therapeutics Questions
Mucone Therapeutics's website is http://www.muconetherapeutics.com
Mucone Therapeutics's LinkedIn profile is https://dk.linkedin.com/company/muconetherapeutics
Mucone Therapeutics's industry is
Pharmaceutical Manufacturing
Mucone Therapeutics's top competitors are
Curasight,
2curex - Individualizing Cancer Treatment,
Ranger Biotechnologies A/s,
Probmet Therapeutics,
Accelerbiotics,
Skape Bio,
Cytovac Ab,
Ovacure - Curing Ovarian Cancer Together,
Amplexa Genetics A/s,
Arcedi Biotech.
Mucone Therapeutics's categories are Pharmaceutical Manufacturing
